NLRP3-IN-84
NLRP3-IN-84 (Compound 32) is a NLRP3 inflammasome inhibitor. NLRP3-IN-84 can interfere with the oligomerization process of NLRP3 by inhibiting the activity of NLRP3 ATPase (IC50 = 158.4 nM) . NLRP3-IN-84 inhibits Caspase-1 (IC50 = 27.7 nM), IL-1β release (PBMC: IC50 = 19.5 nM; mPBMC: IC50 = 24.2 nM), and ASC plaque formation (IC50 = 131 nM) . NLRP3-IN-84 has no inhibitory activity on NLRC4 and AIM2 inflammasomes. NLRP3-IN-84 exhibits significant in vivo anti-inflammatory effects in a mouse acute peritonitis model. NLRP3-IN-84 can be used for the study of NLRP3-related inflammatory diseases[1].
Product Specifications
Target
Caspase; Interleukin Related; NOD-like Receptor (NLR)
Related Pathways
Apoptosis; Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
C[C@H](C1CC1)C2=C(NC(N=[S@](N)(C3=CC(C(C)(O)C)=CO3)=O)=O)C(CC4)=C4C=C2
Molecular Formula
C21H27N3O4S
Molecular Weight
417.52
References & Citations
[1]Chu H, et al. Discovery of novel and potent NLRP3 inflammasome inhibitors with new lipophilic moieties. Eur J Med Chem. 2026 Jan 5;301:118227.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 1; IL-1; NLRP3
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items